Azmi Yerlikaya

Summary

Publications

  1. ncbi request reprint Anticancer Agent Ukrain and Bortezomib Combination is Synergistic in 4T1 Breast Cancer Cells
    Bircan Savran
    Dumlupinar University, Faculty of Medicine, Department of Medical Biology, Kutahya, Turkey
    Anticancer Agents Med Chem 14:466-72. 2014
  2. doi request reprint The p53-independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib
    Azmi Yerlikaya
    Art and Science Faculty, Department of Biology, Dumlupinar University, Kutahya, Turkey
    Tumour Biol 33:1385-92. 2012
  3. ncbi request reprint Investigation of the eIF2alpha phosphorylation mechanism in response to proteasome inhibition in melanoma and breast cancer cells
    Azmi Yerlikaya
    Dumlupinar University, Art and Science Faculty, Department of Biology, Kutahya, Turkey
    Mol Biol (Mosk) 44:859-66. 2010
  4. doi request reprint Effect of bortezomib in combination with cisplatin and 5‑fluorouracil on 4T1 breast cancer cells
    Azmi Yerlikaya
    Department of Medical Biology, Faculty of Medicine, Dumlupinar University, Kutahya 43100, Turkey
    Mol Med Rep 8:277-81. 2013
  5. ncbi request reprint Expression of heme oxygenase-1 in response to proteasomal inhibition
    Azmi Yerlikaya
    Dumlupinar University, Art and Science Faculty, Department of Biology, Kutahya, Turkey
    Protein Pept Lett 19:1330-3. 2012
  6. ncbi request reprint Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade
    Azmi Yerlikaya
    Dumlupinar University, Art and Science Faculty, Department of Biology, Kutahya, Turkey
    Int J Mol Med 22:817-23. 2008
  7. ncbi request reprint The significance of ubiquitin proteasome pathway in cancer development
    Azmi Yerlikaya
    Department of Biology, Art and Science Faculty, Dumlupinar University, Kutahya, 43100, Turkey
    Recent Pat Anticancer Drug Discov 8:298-309. 2013

Collaborators

Detail Information

Publications7

  1. ncbi request reprint Anticancer Agent Ukrain and Bortezomib Combination is Synergistic in 4T1 Breast Cancer Cells
    Bircan Savran
    Dumlupinar University, Faculty of Medicine, Department of Medical Biology, Kutahya, Turkey
    Anticancer Agents Med Chem 14:466-72. 2014
    ..Altogether, the results presented here suggest that the combination of ukrain + bortezomib may be further evaluated and tested in clinical settings. ..
  2. doi request reprint The p53-independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib
    Azmi Yerlikaya
    Art and Science Faculty, Department of Biology, Dumlupinar University, Kutahya, Turkey
    Tumour Biol 33:1385-92. 2012
    ....
  3. ncbi request reprint Investigation of the eIF2alpha phosphorylation mechanism in response to proteasome inhibition in melanoma and breast cancer cells
    Azmi Yerlikaya
    Dumlupinar University, Art and Science Faculty, Department of Biology, Kutahya, Turkey
    Mol Biol (Mosk) 44:859-66. 2010
    ....
  4. doi request reprint Effect of bortezomib in combination with cisplatin and 5‑fluorouracil on 4T1 breast cancer cells
    Azmi Yerlikaya
    Department of Medical Biology, Faculty of Medicine, Dumlupinar University, Kutahya 43100, Turkey
    Mol Med Rep 8:277-81. 2013
    ..It was confirmed that a combination of cisplatin and bortezomib was more effective than each drug as a monotherapy. Therefore, the combination of cisplatin and bortezomib should be tested further in clinical settings...
  5. ncbi request reprint Expression of heme oxygenase-1 in response to proteasomal inhibition
    Azmi Yerlikaya
    Dumlupinar University, Art and Science Faculty, Department of Biology, Kutahya, Turkey
    Protein Pept Lett 19:1330-3. 2012
    ..However, during prolonged incubation with proteasome inhibitors, HO-1 expression can be induced in a p53-independent manner, suggesting participation of other protein(s) with longer half-lives...
  6. ncbi request reprint Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade
    Azmi Yerlikaya
    Dumlupinar University, Art and Science Faculty, Department of Biology, Kutahya, Turkey
    Int J Mol Med 22:817-23. 2008
    ....
  7. ncbi request reprint The significance of ubiquitin proteasome pathway in cancer development
    Azmi Yerlikaya
    Department of Biology, Art and Science Faculty, Dumlupinar University, Kutahya, 43100, Turkey
    Recent Pat Anticancer Drug Discov 8:298-309. 2013
    ..This review summarizes the recent literature and several patented inventions on the ubiquitin proteasome pathway with respect to its role in cancer development and treatment...